Monitoring intraocular proangiogenic and profibrotic cytokines within 7 days after adjunctive anti-vascular endothelial growth factor therapy for proliferative diabetic retinopathy.

MLA

Hu, Zizhong, et al. “Monitoring Intraocular Proangiogenic and Profibrotic Cytokines within 7 Days after Adjunctive Anti-Vascular Endothelial Growth Factor Therapy for Proliferative Diabetic Retinopathy.” Acta Ophthalmologica, vol. 100, no. 3, May 2022, pp. e726–36. EBSCOhost, https://doi.org/10.1111/aos.14957.

APA

Hu, Z., Cao, X., Chen, L., Su, Y., Ji, J., Yuan, S., Fransisca, S., Mugisha, A., Zou, W., Xie, P., & Liu, Q. (2022). Monitoring intraocular proangiogenic and profibrotic cytokines within 7 days after adjunctive anti-vascular endothelial growth factor therapy for proliferative diabetic retinopathy. Acta Ophthalmologica, 100(3), e726–e736. https://doi.org/10.1111/aos.14957

Chicago

Hu, Zizhong, Xin Cao, Lu Chen, Yun Su, Jiangdong Ji, Songtao Yuan, Silvia Fransisca, et al. 2022. “Monitoring Intraocular Proangiogenic and Profibrotic Cytokines within 7 Days after Adjunctive Anti-Vascular Endothelial Growth Factor Therapy for Proliferative Diabetic Retinopathy.” Acta Ophthalmologica 100 (3): e726–36. doi:10.1111/aos.14957.